The lymphocytes of patients with this disease exhibit a large amount of thyroid antibodies due to functional disorders, which disrupt thyroid function and trigger inflammatory reactions.[1–4] After treatment, the IL-6 and IL-17 indicators in the treatment group were significantly lower than those in the control group. This evidence concerns the gene IL6 and thyroid gland disorder.